Sign in
4

Changes in Ownership

aTYR PHARMA INC Filed Acc 0001209191-17-009051

Options or other derivatives

  • Senior Vice President, Finance acquired 65,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Blake John T Senior Vice President, Finance 2017-02-07 Grant or award · Employee Stock Option (right to buy) +55,000 55,000 D
Blake John T Senior Vice President, Finance 2017-02-07 Grant or award · Restricted Stock Unit +10,000 10,000 D
Loading xslF345X03/doc4.xml…